Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persistency of Hib-CRM197 vs Hib-TT in Chinese Children
NCT02139228Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2014
- Primary completion
- Dec 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of VaxemHIB in Haemophilus influenzae type b infection (Hib), sponsored by Novartis. Started Nov 2014; status: completed.
02
Drugs
VaxemHIB
03
Conditions
Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT02139228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02139228.